1CM (MILFF) Beneish M-Score: -2.26 (As of Jun. 26, 2026)


What is 1CM Beneish M-Score?

1CM MILFF Beneish M-Score is -2.26 as of Jun. 26, 2026. The stock has 4 warning signs investors should review. Among 911 Drug Manufacturers companies, 1CM ranks worse than 67.4% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.26 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for 1CM's Beneish M-Score or its related term are showing as below:

MILFF' s Beneish M-Score Range Over the Past 10 Years
Min: -1631.17   Med: -2.04   Max: 66.37
Current: -2.26

During the past 13 years, the highest Beneish M-Score of 1CM was 66.37. The lowest was -1631.17. And the median was -2.04.

1CM Beneish M-Score Historical Data

* Premium members only.

The historical data trend for 1CM's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

1CM Beneish M-Score Chart

1CM Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.29 -1.79 29.29 -1.00 -2.76

1CM Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.81 -2.34 -2.76 -2.41 -2.26

MILFF vs ZTS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, 1CM's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

1CM Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 1CM's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where 1CM's Beneish M-Score falls into.


1CM Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of 1CM for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.8717+0.528 * 0.9444+0.404 * 0.2054+0.892 * 1.1257+0.115 * 0.6664
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.2622+4.679 * -0.047815-0.327 * 0.8588
=-2.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb26) TTM:Last Year (Feb25) TTM:
Total Receivables was $0.93 Mil.
Revenue was 13.069 + 13.655 + 14.275 + 13.208 = $54.21 Mil.
Gross Profit was 2.569 + 2.924 + 3.066 + 2.838 = $11.40 Mil.
Total Current Assets was $26.90 Mil.
Total Assets was $32.31 Mil.
Property, Plant and Equipment(Net PPE) was $2.04 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.62 Mil.
Selling, General, & Admin. Expense(SGA) was $8.71 Mil.
Total Current Liabilities was $6.40 Mil.
Long-Term Debt & Capital Lease Obligation was $1.07 Mil.
Net Income was 2.871 + 0.402 + -0.149 + 0.032 = $3.16 Mil.
Non Operating Income was 2.998 + 0 + 0.005 + -0.042 = $2.96 Mil.
Cash Flow from Operations was 0.344 + 0.494 + -0.898 + 1.8 = $1.74 Mil.
 Total Receivables was $0.44 Mil.
Revenue was 12.45 + 12.564 + 12.155 + 10.983 = $48.15 Mil.
Gross Profit was 2.523 + 2.64 + 2.384 + 2.014 = $9.56 Mil.
Total Current Assets was $8.65 Mil.
Total Assets was $28.22 Mil.
Property, Plant and Equipment(Net PPE) was $5.25 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.97 Mil.
Selling, General, & Admin. Expense(SGA) was $6.13 Mil.
Total Current Liabilities was $3.80 Mil.
Long-Term Debt & Capital Lease Obligation was $3.80 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.925 / 54.207) / (0.439 / 48.152)
=0.017064 / 0.009117
=1.8717

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(9.561 / 48.152) / (11.397 / 54.207)
=0.198559 / 0.21025
=0.9444

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (26.901 + 2.044) / 32.312) / (1 - (8.654 + 5.247) / 28.219)
=0.104203 / 0.507389
=0.2054

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=54.207 / 48.152
=1.1257

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.966 / (0.966 + 5.247)) / (0.622 / (0.622 + 2.044))
=0.15548 / 0.233308
=0.6664

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(8.71 / 54.207) / (6.13 / 48.152)
=0.16068 / 0.127305
=1.2622

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1.069 + 6.402) / 32.312) / ((3.798 + 3.799) / 28.219)
=0.231214 / 0.269216
=0.8588

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(3.156 - 2.961 - 1.74) / 32.312
=-0.047815

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

1CM has a M-score of -2.18 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.26 mean?
1CM (MILFF) has a Beneish M-Score of -2.26 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on 1CM and its competitors. According to the industry distribution chart, 1CM ranks #614 out of 911 companies in the Drug Manufacturers industry, placing it in the top 67.4%.
Is 1CM's Beneish M-Score too high?
1CM's current Beneish M-Score is -2.26. Based on the distribution chart, 1CM ranks #614 out of 911 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does 1CM's Beneish M-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, 1CM ranks #614 out of 911 companies for Beneish M-Score. This places 1CM in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on 1CM and its competitors. 1CM's current Beneish M-Score is -2.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 1CM stock overvalued right now?
Based on GuruFocus' analysis, 1CM (MILFF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.27, compared to a current price of $0.08 — trading 71.1% below its estimated fair value. The current Beneish M-Score is -2.26. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For 1CM (MILFF), the current Beneish M-Score is -2.26 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

1CM Business Description

Other Exchanges EPIC:Canada
Address 625 Cochrane Drive, Suite 802, Markham, ON, CAN, L3R9R9
1CM Inc is a multi-jurisdictional cannabis company focused on its retail customers and technology to democratize cannabis markets. The Company focuses on expanding its current operations through organic growth and by way of merger and acquisition transactions. It has a single operating segment, being Cannabis.